Hyperbilirubinemia News and Research

RSS
MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

FDA approval provides new, targeted treatment option for adults with relapsed or refractory B-cell ALL

Stivarga receives expanded FDA approval for treatment of liver cancer

Stivarga receives expanded FDA approval for treatment of liver cancer

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study reveals promising results for primary liver cancer patients treated with SIR-Spheres Y-90 resin microspheres

Study could provide novel therapeutic approach for preventing severe jaundice in newborn babies

Study could provide novel therapeutic approach for preventing severe jaundice in newborn babies

New method could help detect unconjugated bilirubin in newborn infants

New method could help detect unconjugated bilirubin in newborn infants

Studies explore possible link between pediatric cancer and light therapy for newborn jaundice

Studies explore possible link between pediatric cancer and light therapy for newborn jaundice

Researchers suggest potential method of screening for jaundice in preterm infants

Researchers suggest potential method of screening for jaundice in preterm infants

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

FDA approves intravenous administration of Erwinaze (asparaginase Erwinia chrysanthemi)

New study details weight loss patterns of breastfed newborns

New study details weight loss patterns of breastfed newborns

European Commission approves Exelixis' COMETRIQ for treatment of progressive, metastatic MTC

European Commission approves Exelixis' COMETRIQ for treatment of progressive, metastatic MTC

Neonatal jaundice linked to pediatric asthma risk

Neonatal jaundice linked to pediatric asthma risk

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Pivotal Phase III STARTVerso data shows efficacy of faldaprevir in genotype-1 infected HCV patients

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

Exelixis announces FDA approval of COMETRIQ for treatment of medullary thyroid cancer

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

European Medicines Agency accepts Exelixis’ COMETRIQ MAA for review

Neonatal history must be taken in ex-preterms with fractures

Neonatal history must be taken in ex-preterms with fractures

Lilly, Kowa announce results from PREVAIL U.S. study

Lilly, Kowa announce results from PREVAIL U.S. study

New data from descriptive sub-analysis of patients with compensated liver cirrhosis

New data from descriptive sub-analysis of patients with compensated liver cirrhosis